Info: Zenodo’s user support line is staffed on regular business days between Dec 23 and Jan 5. Response times may be slightly longer than normal.

Published July 23, 2018 | Version v1
Journal article Restricted

Encapsulation of young donor age dopaminergic grafts in a GDNF-loaded collagen hydrogel further increases their survival, reinnervation, and functional efficacy after intrastriatal transplantation in hemi-Parkinsonian rats

  • 1. Pharmacology and Therapeutics, National University of Ireland, Galway, Ireland
  • 2. CÚRAM Centre for Research in Medical Devices, National University of Ireland, Galway, Ireland

Description

Biomaterials have been shown to significantly improve the outcome of cellular reparative approaches for Parkinson’s disease in experimental studies because of their ability to provide transplanted cells with a supportive microenvironment and shielding from the host immune system. However, given that the margin for improvement in such reparative therapies is considerable, further studies are required to fully investigate and harness the potential of biomaterials in this context. Given that several recent studies have demonstrated improved brain repair in Parkinsonian models when using
dopaminergic grafts derived from younger foetal donors, we hypothesized that encapsulating these cells in a supportive biomaterial would further improve their reparative efficacy. Thus, this study aimed to determine the impact of a GDNF-loaded collagen hydrogel on the survival, reinnervation, and functional efficacy of dopaminergic neurons derived from young donors. To do so, hemi-Parkinsonian (6-hydroxydopamine-lesioned) rats received intrastriatal transplants of embryonic day 12 cells extracted from the rat ventral mesencephalon either alone, in a collagen hydrogel, with GDNF,
or in a GDNF-loaded collagen hydrogel. Methamphetamine-induced rotational behaviour was assessed at three weekly intervals for a total of 12 weeks, after which rats were sacrificed for postmortem assessment of graft survival. We found that, following intrastriatal transplantation to the lesioned striatum, the GDNF-loaded collagen hydrogel significantly increased the survival (4-fold), reinnervation (5.4-fold), and functional efficacy of the embryonic day 12 dopaminergic neurons. In conclusion, this study further demonstrates the significant potential of biomaterial hydrogel scaffolds
for cellular brain repair approaches in neurodegenerative diseases such as Parkinson’s disease.

Notes

Funded by: Irish Research Council, Grant/Award Number: 11/RFP/NES/3183 and European Union Horizon 2020 Programme, Grant/Award Number: H2020-MSCA-ITN-2015

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.

Additional details

Funding

BrainMatTrain – Development of Biomaterial-based Delivery Systems for Parkinson’s disease - an Integrated Pan-European Approach 676408
European Commission